Answers are grounded in this paper and cite their sources.
There have been encouraging recent successes in the development of safe and effective topical microbicides to prevent vaginal or rectal HIV-1 transmission, based on the use of anti-retroviral drugs. However, much work remains to be accomplished before a microbicide becomes a standard element of prevention science strategies. Animal models should continue to play an important role in pre-clinical testing, with emphasis on safety, pharmacokinetic and efficacy testing.
No takes yet. Share an insight, caveat, or question.
Veazey et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: